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Abstract
Background: Studies examining the association between smoking and the need for surgery in patients with Crohn’s
disease and ulcerative colitis have reached inconsistent conclusions. These studies often do not differentiate between
patients undergoing early surgery and patients having surgery later in their disease course. Our study examined the
association between smoking status and time to first bowel resection in patients with Crohn’s disease and ulcerative
colitis.
Methods: We searched MEDLINE and EMBASE for studies (n = 12) reporting on the association between smoking
status (current, former, and never) and surgery in IBD, and incorporated disease duration in the analysis. Hazard ratios
(HR) with 95% confidence intervals (CI) were pooled across studies using random effects models.
Results: Current smokers with Crohn’s disease were at increased risk of intestinal resection compared to never smokers
(HR 1.27, 95% CI 1.08 to 1.49); however, there was no difference in the need for surgery when comparing former and
never smokers (HR 1.11, 95% CI 0.95 to 1.30). In patients with ulcerative colitis, there was no difference in the need for
colectomy when comparing current smokers to never smokers (HR 0.98, 95% CI 0.67 to 1.44). Former smokers with
ulcerative colitis were at increased risk of colectomy (HR 1.38, 95% CI 1.04 to 1.83) compared to never smokers.
Conclusions: Current smokers with Crohn’s disease are at increased risk of surgery, while former smokers with
ulcerative colitis have increased risk of colectomy.
Keywords: Crohn’s disease, Ulcerative colitis, Inflammatory bowel disease, Cigarette smoking, Intestinal resection,
Colectomy, Survival analysis, Meta-analysis
Background
Cigarette smoking exhibits a paradoxical relationship
with the inflammatory bowel diseases (IBD), with
smokers being at increased risk of developing Crohn’s
disease and at decreased risk of developing ulcerative
colitis [1]. Smoking also worsens the prognosis of
Crohn’s disease by increasing the risk of penetrating and
fibrostenotic complications, as well as the risk of disease
recurrence following intestinal resection [2, 3]. Quitting
smoking after the diagnosis of Crohn’s disease is associ-
ated with a decrease in the risk of a disease flare [4, 5].
However, studies assessing the association between
smoking and the need for intestinal resection in
patients with Crohn’s disease have reached different
conclusions with some demonstrating that smoking
increases the risk of intestinal resection and others
showing no association [6–14]. Similarly, studies exam-
ining the association between smoking and colectomy
in patients with ulcerative colitis have demonstrated
inconsistent results; some studies suggest that former
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smokers are more likely to require surgery, while others
dispute this association [14–17].
A potential explanation for the heterogeneous results
between studies may be the time lapse between diagnosis
and first surgery. The need for intestinal resection in pa-
tients with Crohn’s disease increases from 16% in the first
year following diagnosis to nearly 50% within a decade of
diagnosis [18]. Similarly, the proportion of patients with
ulcerative colitis requiring colectomy triples from 5%
within a year of diagnosis to 16% after 10 years [18]. Thus,
accounting for disease duration may be important when
studying associations between smoking and surgery in
IBD. Disease duration was not evaluated in previous
meta-analyses exploring the association between smok-
ing and surgery in IBD [19, 20]. Heterogeneity may also
result from differences in the definition of smoking across
studies. Many studies dichotomize exposure to smoking,
grouping former smokers with current smokers and
comparing them to lifetime never smokers. However, due
to the differential effects between former and current
smokers observed in many observational studies in IBD
[21], combining groups of smokers may introduce
misclassification bias that could mask important differences
between current and former smokers.
Thus, the objective of this systematic review and
meta-analysis was to examine the associations between
smoking status (current, former, and never) and first
intestinal resection, accounting for disease duration in
patients with Crohn’s disease and ulcerative colitis.
Methods
This systematic review and meta-analysis was based on
a previously published protocol [22] and is reported in
accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-analyses (PRISMA)
guidelines [23].
Study identification and selection
A structured literature search was performed using
MEDLINE (1946 – April 29, 2016) and EMBASE (1974
– April 29, 2016) databases to identify observational
studies examining the association between cigarette
smoking and the requirement for first surgery in patients
with IBD (Additional file 1: Table S1). We did not
restrict the search by language, date of publication, or
region of study. We hand searched references of
included studies and relevant review articles. The follow-
ing conference proceedings from gastroenterology meet-
ings are indexed in EMBASE and were included in the
search: Digestive Diseases Week 2009–2015; American
College of Gastroenterology Annual Scientific Meeting
2010–2015; and Congress of the European Crohn’s and
Colitis Organization 2011–2015. Two study authors
(MEK and SML) independently screened the full-text
abstracts. The kappa statistic was used to evaluate agree-
ment between reviewers. A third author (GGK) resolved
disagreements.
Studies were eligible for inclusion if they were: (1) an
observational epidemiological study; (2) reported on
patients with Crohn’s disease and/or ulcerative colitis;
(3) assessed cigarette smoking and separately analyzed
current, former, and never smokers; (4) reported on first
abdominal surgery (i.e., first intestinal resection) in
Crohn’s disease or colectomy in ulcerative colitis; and
(5) incorporated disease duration in the analysis using
Kaplan-Meier curves and/or hazard ratios (HR) and con-
fidence intervals (CI).
Studies were excluded if (1) they were case series or case
reports; (2) assessed the association between smoking and
surgery in patients with IBD undetermined (IBD-U) only;
(3) reported only on perianal surgeries in patients with
Crohn’s disease; (4) were unable to differentiate between
first surgery and later surgeries in patients with Crohn’s
disease; and (5) reported only on surgeries required for
dysplasia or cancer in patients with ulcerative colitis. We
additionally excluded studies where current smoking
was used as the reference group to ensure the smoking-
surgery association was reported consistently across all
included studies. When the same cohort of patients
was reported in more than one manuscript, we selected
the study with the most complete data.
Data extraction and study quality
Two study authors (MEK and SML) used a standardized
data extraction form to independently extract data from
eligible studies, including: study design (e.g., source of
patients); definitions and source of exposure to cigarette
smoke; time to surgery; study location; sample size; and
the association between smoking and surgery (e.g., HRs
and CIs). The Newcastle-Ottawa Scale was used to as-
sess the quality of individual studies [24]. The scale was
adapted to include components of study quality specific
to surgical outcomes in IBD (e.g., combining abdom-
inal and perianal surgeries in the definition of surgery
in patients with Crohn’s disease) and the assessment
of proportional hazards assumption in the statistical
analysis.
Study design and outcomes
Our primary outcomes were: (1) requirement for first in-
testinal resection in patients with Crohn’s disease; and
(2) need for colectomy in patients with ulcerative colitis.
Both outcomes were compared for current, former, and
never smokers.
Statistical analysis
Data were analyzed using Stata 12.1 (StataCorp. 2011.
Stata Statistical Software: Release 12. College Station,
Kuenzig et al. BMC Gastroenterology  (2016) 16:143 Page 2 of 9
TX: StataCorp LP). HRs and 95% CIs were pooled using
random effects models to account for expected variabil-
ity between studies. The most-adjusted HR was used
when available. The method proposed by Guyot et al.
was used to calculate HRs from Kaplan-Meier curves
when HRs were not included in the manuscript [25].
When studies differentiated between heavy and light
smokers, the HR comparing heavy smokers to never
smokers was used in the meta-analysis. Studies reporting
stratified associations between smoking and surgery
were pooled using fixed effects analysis prior to being
included in the primary analysis.
The I2 measure and the Cochran Q statistic were
used to assess for heterogeneity with p < 0.10 consid-
ered statistically significant. We were not able to assess
for publication bias due to the small number of studies
included [26].
A pre-determined subgroup analysis was based on the
method used to identify patients for the study (i.e.,
population-based cohorts vs. tertiary-care centres). We
did not have enough studies to conduct meta-regression
to look for differences between subgroups [27]. We con-
ducted the following sensitivity analyses based on the
presentation of results in identified studies: (1) replacing
the HR comparing heavy smokers to never smokers with
the HR for light smokers compared to never smokers; and
(2) substituting the age-specific estimates (i.e., 17–40 and
>40 years of age at diagnosis) into the pooled analysis,
replacing the pooled estimate of the stratum-specific HRs.
Results
Description of included studies
The database search identified 2437 records; 2025 records
remained after removing duplicates (Additional file 2:
Figure S1). The full-text of 327 records were reviewed, in-
cluding 96 conference abstracts. Eleven studies were eligible
for inclusion: seven reported on Crohn’s disease [6–10, 12,
13], three reported on ulcerative colitis [15–17], and one
study reported on both Crohn’s disease and ulcerative col-
itis [14]. One included study was published as a conference
abstract [12]. One additional study, reporting on the associ-
ation between smoking and surgery in Crohn’s disease, was
identified after reviewing references of review articles and
included studies [11]. Fair agreement was observed between
reviewers for assessment of abstracts (κ = 0.34, 95% CI 0.28
to 0.41), and full-text articles (κ = 0.37, 95% CI 0.15 to
0.60). Table 1 (Crohn’s disease) and Table 2 (ulcerative col-
itis) outline the characteristics of included studies. A list of
excluded peer-reviewed manuscripts and reasons for exclu-
sion are provided in Additional file 3: Table S2.
Methodological quality of included studies
The quality of included Crohn’s disease and ulcerative
colitis studies is described in Additional file 4: Table S3
and Additional file 5: Table S4, respectively. Only two
studies clearly differentiated ulcerative colitis from
IBD-U [14, 17]. Five studies recruited patients from
tertiary-care centres [6–8, 10, 15], five studies were
population-based [9, 11, 13, 14, 17], one study used
data from a health maintenance organization (HMO)
[16]. The source of patients was unclear in the
remaining study [12]. Seven studies that examined the
smoking-surgery association in Crohn’s disease were
limited to ileocolonic resections [6–9, 11, 13, 14]; one
study grouped abdominal and perianal surgeries as a
single outcome [10] and this was unclear in the final
study [12].
Smoking and first surgical resection in Crohn’s disease
The risk of first surgery was significantly increased in
current smokers as compared to never smokers (pooled
HR 1.27, 95% CI 1.08 to 1.49, 9 studies; heterogeneity:
I2 = 24%, p = 0.23) (Fig. 1). However, former smokers
were not at an increased risk of surgery relative to never
smokers (pooled HR 1.11, 95% CI 0.95 to 1.30, 9 studies;
heterogeneity: I2 = 0%, p = 0.60) (Fig. 1). Findings
remained consistent when substituting the HR for pa-
tients diagnosed between the ages of 17 and 40 and the
HR for patients diagnosed after age 40 in the pooled
analysis (Additional file 6: Table S5).
One study differentiated between light and heavy
current smokers [11]. When the HR comparing light
smokers to never smokers was substituted into the
meta-analysis, current smoking remained significantly
associated with an increased risk of surgery (pooled
HR 1.20, 95% CI 1.03 to 1.40, 9 studies; heterogen-
eity: I2 = 18%, p = 0.28) (Additional file 7: Figure S2).
Subgroup analysis based on patient recruitment in-
dicated that current smoking increased the risk of
surgery in population-based studies (HR 1.48, 95% CI
1.15 to 1.90, 4 studies), but not in patients recruited
from tertiary-care centres (HR 1.17, 95% CI 0.94 to
1.46, 4 studies) (Additional file 8: Table S6). Former
smokers were not at increased risk of surgery relative
to never smokers regardless of the method of patient
recruitment.
Smoking and colectomy in ulcerative colitis
Current smokers were not at increased risk of colectomy
compared to never smokers (pooled HR 0.98, 95% CI
0.67 to 1.44, 4 studies; heterogeneity: I2 = 0%, p = 0.65)
(Fig. 2). However, former smokers were significantly
more likely to require a colectomy compared to never
smokers (pooled HR 1.38, 95% CI 1.04 to 1.83, 4 studies;
heterogeneity: I2 = 0%, p = 0.78) (Fig. 2). When pooling
studies reporting on the need for colectomy among
patients diagnosed between 17 and 40 years of age, the
results remained consistent; however, there was no
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Fig. 2 Forest plot depicting the association between smoking and need for colectomy in patients with ulcerative colitis, comparing current to
never smokers and former to never smokers
Fig. 1 Forest plot depicting the association between smoking and the need for first surgery in patients with Crohn’s disease comparing current
to never smokers and former to never smokers
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longer an association between former smoking and
the need for colectomy among patients diagnosed
with ulcerative colitis after 40 years of age (Additional
file 6: Table S5).
Results were consistent in studies in population-based
studies and studies based on patients enrolled in an
HMO; however, former smoking was no longer associ-
ated with the need for colectomy in patients recruited
from tertiary-care centres (Additional file 8: Table S6).
Discussion
This is the first systematic review and meta-analysis of
the smoking-surgery association in patients with IBD to
incorporate disease duration by including only studies
that used time-to-event analyses (Additional file 9). Pa-
tients with Crohn’s disease who are current smokers are
at increased risk of requiring a first intestinal resection
as compared to those who never smoked. In contrast,
former smokers were not more likely to need surgery for
Crohn’s disease. Patients with ulcerative colitis who were
former smokers were at increased risk of colectomy as
compared to never smokers. Current smokers were not
more likely to require colectomy for ulcerative colitis.
Similar to our findings, a previous meta-analysis asses-
sing the smoking-surgery association in patients with
Crohn’s disease demonstrated the increased risk of first
surgery among current smokers, but not among former
smokers [19]. However, our findings contradict a previ-
ous meta-analysis that showed when current and former
smokers were combined, smoking decreased the need
for colectomy in patients with ulcerative colitis [20].
This dichotomization of smoking status (i.e., combining
current and former smokers) occurs in the majority of
studies examining the association between smoking and
the need for surgery in patients with IBD. However, our
study suggests that treating current and former smokers
as the same introduces a misclassification bias that blurs
the separate effects of current and former smoking on
the need for surgery.
We restricted our analysis to studies that accounted
for disease duration in order to allow for the potential
differential effects of smoking on surgery over time.
Studies that do not incorporate disease duration treat
patients with IBD who undergo surgery three years fol-
lowing diagnosis in the same fashion as those who will
require surgery 15 years after diagnosis. When incorpor-
ating time, our meta-analysis showed that former
smokers with ulcerative colitis were at increased risk of
colectomy compared to never smokers. In contrast, a
prior meta-analysis that did not use a time-to-event ana-
lysis showed no difference in the odds of colectomy for
former and never smokers [28].
Our systematic review identified a paucity of primary
studies that examined the effect of more refined
definitions of smoking (e.g., dose, duration, and cumula-
tive exposure) or treated smoking as a time-varying covar-
iate. Consequently, we were not able to meaningfully
incorporate these elements of smoking into our meta-
analysis. These are important considerations because
prognosis improves after quitting smoking and the risk of
a negative outcome (e.g., disease flare) decreases with time
among patients with Crohn’s disease [4, 5]. Future primary
studies should consider potential differences between
light, moderate, and heavy smokers, as well as potential
differences in duration of smoking and cumulative expos-
ure to cigarette smoke (e.g., pack years).
Our systematic review identified one study that strati-
fied the smoking-surgery association by age at diagnosis
[14]. This study showed that smoking at diagnosis
increased the risk of surgery for Crohn’s disease patients
diagnosed after the age of 40, but not for those diag-
nosed before age 40. In contrast, ulcerative colitis
patients diagnosed between the ages of 17 and 40 years
and who quit smoking prior to their diagnosis were
more likely to undergo a colectomy, but this association
was not observed among patients diagnosed with ulcera-
tive colitis after the age of 40 years. In our sensitivity
analysis, smoking remained associated with surgery for
Crohn’s disease when we included the age-specific risk
estimates. In contrast, smoking was only associated with
the need for colectomy when we included the risk esti-
mate for patients diagnosed with ulcerative colitis before
40 years of age. Future studies may need to account for
age at diagnosis when exploring a relationship between
smoking and surgery for IBD.
Although our study provides a comprehensive summary
of studies that have investigated the association between
smoking and surgery in patients with IBD, it is not with-
out limitations. Firstly, with the exception of disease dur-
ation, we did not account for confounding and effect
measure modification. The association between smoking
and surgery could be influenced by age at diagnosis, dis-
ease location, disease behaviour, and/or medications used
to treat IBD. Further, ethnic differences may play an add-
itional role on this association, with recent evidence sug-
gesting that the impact of smoking on the development of
Crohn’s disease varies across ethnicities [29, 30]. Secondly,
selection bias in defining the study populations may have
introduced bias in our analyses. For example, the associ-
ation between time to surgery and current smoking in pa-
tients with Crohn’s disease was significant in population-
based studies, but not in tertiary-care centres. Patients
followed in the community may be at decreased risk of
surgery and possibly less likely to be smokers. Thirdly,
while we accounted for disease duration, we were unable
to analyze the impact of smoking on the need for surgery
at a specific time point in the disease course such as at
diagnosis or three years following diagnosis.
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Conclusions
After accounting for disease duration, our meta-analysis
confirms that cigarette smoking is an important risk
factor for surgery in patients with IBD, with current
smoking increasing the risk of intestinal resection
among patients with Crohn’s disease and former smok-
ing increasing the risk of colectomy among patients with
ulcerative colitis. Additionally, our systematic review
identified important gaps in the literature. In addition to
accounting for disease duration, future studies examin-
ing smoking as a risk factor for surgery in patients with
IBD should capture detailed smoking information such
as dose and duration, and evaluate potential effect meas-
ure modification by factors such as age at diagnosis.
Additional files
Additional file 1: Table S1. Search strategy. (DOCX 84 kb)
Additional file 2: Figure S1. Study flow diagram. (DOCX 108 kb)
Additional file 3: Table S2. List of excluded peer-reviewed manuscripts.
(DOCX 301 kb)
Additional file 4: Table S3. Quality of studies assessing the association
between smoking and time to first surgery in patients with Crohn’s
disease. (DOCX 129 kb)
Additional file 5: Table S4. Quality of studies assessing the association
between smoking and colectomy in patients with ulcerative colitis.
(DOCX 117 kb)
Additional file 6: Table S5. Sensitivity analysis substituting age-specific
smoking-surgery analyses into the overall estimate. (DOCX 75 kb)
Additional file 7: Figure S2. Forest plot depicting the association
between smoking and first intestinal resection in patients with Crohn’s
disease when substituting the hazard ratio for heavy smoking with that
of light smoking. (DOCX 174 kb)
Additional file 8: Table S6. Subgroup analysis based on source of
patients with Crohn’s disease and ulcerative colitis. (DOCX 66 kb)
Additional file 9: Raw study Data. Excel file containing hazard ratios
from individual studies included in the meta-analysis. (XLSX 45 kb)
Abbreviations
CI: Confidence interval; HMO: Health maintenance organization; HR: Hazard
ratio; IBD: Inflammatory bowel disease; PRISMA: Preferred reporting items for
systematic reviews and meta-analyses; SD: Standard deviation
Funding
None.
Availability of data and materials
The dataset supporting the conclusions of this article is included as a
supplementary file.
Authors’ contributions
Study concept and design: MEK, BE, CHS, CB, GGK. Data acquisition: MEK,
SML, GGK. Interpretation of the data: MEK, SML, BE, CHS, CB, RP, GGK.
Statistical analysis: MEK, GGK. Drafting of the manuscript: MEK, BE, CHS, CB,
GGK. Critical revision of the manuscript for important intellectual content:
SML, RP. Final approval of the manuscript: MEK, SML, BE, CHS, CB, RP, GGK.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Author details
1Department of Medicine, University of Calgary, 3280 Hospital Drive NW,
6D56, Calgary, AB T2N 4N1, Canada. 2Department of Community Health
Sciences, University of Calgary, Calgary, AB, Canada. 3Synder Institute for
Chronic Diseases, University of Calgary, Calgary, AB, Canada. 4O’Brien Institute
for Public Health, University of Calgary, Calgary, AB, Canada.
Received: 8 June 2016 Accepted: 6 December 2016
References
1. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel
disease. Dig Dis Sci. 1989;34:1841–54.
2. Mahid SS, Minor KS, Stevens PL, Galandiuk S. The role of smoking in
Crohn’s disease as defined by clinical variables. Dig Dis Sci. 2007;52:
2897–903.
3. Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP.
The effect of smoking after surgery for Crohn’s disease: a meta-analysis
of observational studies. Int J Colorectal Dis. 2008;23:1213–21.
4. Cosnes J, Beaugerie L, Carbonnel F, Gendre J-P. Smoking cessation and the
course of Crohn’s disease: an intervention study. Gastroenterology. 2001;
120:1093–9.
5. Nunes T, Etchevers MJ, García-Sánchez V, Ginard D, Martí E, Barreiro-de
Acosta M, Gomollón F, Arroyo M, Bastida G, Gonzalez B, Monfort D,
García-Planella E, Figueroa C, Panes J, Sans M. Impact of smoking
cessation on the clinical course of Crohn’s disease under current
therapeutic algorithms: a multicenter prospective study. Am J
Gastroenterol. 2016;111:411–9.
6. Kariyawasam VC, Selinger CP, Katelaris PH, Jones DB, McDonald C, Barr G,
Chapman G, Colliwshaw J, Lunney PC, Middleton K, Wang RR, Huang T,
Andrews J, Leong RW. Early use of thiopurines or methotrexate reduces
major abdominal and perianal surgery in Crohn’s disease. Inflamm Bowel
Dis. 2014;20:1382–90.
7. Lawrance IC, Murray K, Batman B, Gearry RB, Grafton R, Krishnaprasad K,
Andrews JM, Prosser R, Bampton PA, Cooke SE, Mahy G, Radford-Smith G,
Croft A, Hanigan K. Crohn’s disease and smoking: is it ever too late to quit?
J Crohns Colitis. 2013;7:e665–71.
8. Moon CM, Park DI, Kim ER, Kim YH, Lee CK, Lee SH, Kim JH, Huh KC, Jung
SA, Yoon SM, Song HJ, Jang HJ, Kim YS, Lee KM, Shin JE. Clinical features
and predictors of clinical outcomes in Korean patients with Crohn’s
disease: a Korean association for the study of intestinal diseases
multicenter study. J Gastroenterol Hepatol. 2014;29:74–82.
9. Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sandborn WJ,
Loftus EV. Surgery in a population-based cohort of Crohn’s disease from
Olmsted County, Minnesota (1970–2004). Am J Gastroenterol. 2012;107:
1693–701.
10. Renda MC, Orlando A, Civitavecchia G, Criscuoli V, Maggio A, Mocciaro F,
Rossi F, Scimeca D, Modesto I, Oliva L, Cottone M. The role of CARD15
mutations and smoking in the course of Crohn’s disease in a Mediterranean
area. Am J Gastroenterol. 2008;103:649–55.
11. Solberg IC, Vatn MH, Høie O, Stray N, Sauar J, Jahnsen J, Moum B, Lygren I.
Clinical course in Crohn’s disease: results of a Norwegian population-based
ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430–8.
12. Deepak P, Fletcher JG, Fidler JL, Barlow JM, Sheedy S, Kolbe AB, Harmsen
WS, Loftus EV, Hansel SL, Becker BD, Bruining DH. Radiologic and clinical
features as predictors of future hospitalizations for active Crohn’s disease,
surgeries, and the need for corticosteroids in patients with small bowel
Crohn’s disease. Gastroenterology. 2015;148:S479–80.
13. Ng SC, Zeng Z, Niewiadomski O, Tang W, Bell S, Kamm MA, Hu P, de Silva
HJ, Niriella MA, Udara WSAAY, Ong D, Ling KL, Ooi CJ, Hilmi I, Lee Goh K,
Ouyang Q, Wang YF, Wu K, Wang X, Pisespongsa P, Manatsathit S, Aniwan
S, Limsrivilai J, Gunawan J, Simadibrata M, Abdullah M, Tsang SWC, Lo FH,
Hui AJ, Chow CM, et al. Early course of inflammatory bowel disease in a
population-based inception cohort study from 8 countries in Asia and
Australia. Gastroenterology. 2016;86:95.e3.
14. Frolkis AD, de Bruyn J, Jette N, Lowerison M, Engbers J, Ghali W, Lewis JD,
Vallerand I, Patten S, Eksteen B, Barnabe C, Panaccione R, Ghosh S, Wiebe
S, Kaplan GG. The association of smoking and surgery in inflammatory
Kuenzig et al. BMC Gastroenterology  (2016) 16:143 Page 8 of 9
bowel disease is modified by age at diagnosis. Clin Transl Gastroenterol.
2016;7:e165.
15. Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP, Cosnes J. Impact of
cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol.
2001;96:2113–6.
16. Boyko EJ, Perera DR, Koepsell TD, Keane EM, Inui TS. Effects of cigarette
smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol.
1988;23:1147–52.
17. Hoie O, Wolters FL, Riis L, Bernklev T, Aamodt G, Clofent J, Tsianos E,
Beltrami M, Odes S, Munkholm P, Vatn M, Stockbrugger RW, Moum B. Low
colectomy rates in ulcerative colitis in an unselected European cohort
followed for 10 years. Gastroenterology. 2007;132:507–15.
18. Frolkis AD, Dykeman J, Negrón ME, DeBruyn J, Jette N, Fiest KM, Frolkis T,
Barkema HW, Rioux KP, Panaccione R, Ghosh S, Wiebe S, Kaplan GG. Risk of
surgery for inflammatory bowel diseases has decreased over time: a
systematic review and meta-analysis of population-based studies.
Gastroenterology. 2013;145:996–1006.
19. To N, Gracie DJ, Ford AC. Systematic review with meta-analysis: the adverse
effects of tobacco smoking on the natural history of Crohn’s disease.
Aliment Pharmacol Ther. 2016;43:549–61.
20. Dias CC, Rodrigues PP, Costa-Pereira AD, Magro F. Clinical predictors of
colectomy in patients with ulcerative colitis: systematic review and
meta-analysis of cohort studies. J Crohns Colitis. 2015;9:156–63.
21. Molodecky NA, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Challenges
associated with identifying the environmental determinants of the
inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:1792–9.
22. Kuenzig E, Kaplan G, Lee S. Examining heterogeneity in the association
between cigarette smoking and the need for surgery in the inflammatory
bowel diseases: a systematic review and meta-analysis. PROSPERO 2015,
CRD42015023525.
23. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA
statement. PLoS Med. 2009;6:e1000097–6.
24. The Newcastle-Ottawa Scale (NOS) for assessing the quality of
nonrandomised studies in meta-analyses [http://www.ohri.ca/programs/
clinical_epidemiology/oxford.asp]. Accessed 5 July 2015.
25. Guyot P, Ades AE, Ouwens MJNM, Welton NJ. Enhanced secondary analysis
of survival data: reconstructing the data from published Kaplan-Meier
survival curves. BMC Med Res Methodol. 2012;12:9.
26. Sterne JAC, Egger M, Moher D, Cochrane Bias Methods Group. Addressing
reporting biases. Edited by Higgins JPT, Green S. The Cochrane
Collaboration; 2011.
27. Deeks JJ, Higgins JPT, Altman DG, Cochrane Statistical Methods Group.
Analysing data and undertaking meta‐analyses. In Cochrane Handbook for
Systematic Reviews of Interventions. Edited by Higgins JPT, Green S. John
Wiley & Sons, Ltd; 2011.
28. To N, Ford AC, Gracie DJ. Systematic review with meta-analysis: the effect of
tobacco smoking on the natural history of ulcerative colitis. Aliment
Pharmacol Ther. 2016;44:117–26.
29. Ng SC, Tang W, Leong RW, Chen M, Ko Y, Studd C, Niewiadomski O, Bell S,
Kamm MA, de Silva HJ, Kasturiratne A, Senanayake YU, Ooi CJ, Ling K-L, Ong D,
Goh KL, Hilmi I, Ouyang Q, Wang Y-F, Hu P, Zhu Z, Zeng Z, Wu K, Wang X, Xia B,
Li J, Pisespongsa P, Manatsathit S, Aniwan S, Simadibrata M, et al. Environmental
risk factors in inflammatory bowel disease: a population-based case–control study
in Asia-Pacific. Gut. 2015;64:1063–71.
30. Niu J, Miao J, Tang Y, Nan Q, Liu Y, Yang G, Dong X, Huang Q, Xia S, Wang
K, Miao Y. Identification of environmental factors associated with
inflammatory bowel disease in a southwestern highland region of China: a
nested case–control study. PLoS One. 2016;11:e0153524.
31. Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Stray N, Sauar J,
Schulz T. Incidence of Crohn’s disease in four counties in southeastern
Norway, 1990–93. A prospective population-based study. The Inflammatory
Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists.
Scand J Gastroenterol. 1996;31:355–61.
32. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van
Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there
a difference between north and south? Results of the European Collaborative
Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39:690–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Kuenzig et al. BMC Gastroenterology  (2016) 16:143 Page 9 of 9
